Archives

Olympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio

B Partnership Aimed at Expanding Patient Access to Advanced EndoTherapeutic Procedures TOKYO, May 4, 2026 /PRNewswire/ — Olympus Corporation (Olympus), a global MedTech company committed to… Login to continue reading Login…

Read MoreOlympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio

Results of the Randomized Controlled Trial of At-Home Subcutaneous Diuretic Therapy for Heart-Failure Associated Edema to Be Presented at Heart Failure 2026

B Results of SUBCUT HF II, the first full-scale outcomes trial of subcutaneous furosemide for at-home treatment of edema in heart failure patients, to be… Login to continue reading Login…

Read MoreResults of the Randomized Controlled Trial of At-Home Subcutaneous Diuretic Therapy for Heart-Failure Associated Edema to Be Presented at Heart Failure 2026

CTCI Ranked No. 1 in Sustainability Among Global Construction & Engineering Firms for Fourth Straight Year; Maintains Inclusion in Dow Jones Best-in-Class Emerging Markets Index

B TAIPEI, May 4, 2026 /PRNewswire/ — CTCI Corporation, committed to its mission as a “Guardian of Sustainable Earth,” announced today that, with a score… Login to continue reading Login…

Read MoreCTCI Ranked No. 1 in Sustainability Among Global Construction & Engineering Firms for Fourth Straight Year; Maintains Inclusion in Dow Jones Best-in-Class Emerging Markets Index

Manhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

B NEW YORK, May 4, 2026 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties… Login to continue reading Login…

Read MoreManhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH